Want to join the conversation?
UBS analyst Michael Binetti questions about the planned cost saving split between SG&A and COGS in 2Q17 and 2H17. $RL says that majority of its restructuring activities are heavily weighted to 2H17. The gross savings relative to the Way Forward Plan are $445MM. This represents SG&A savings and not net savings that will drop to the bottom line.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?